Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Robotically assisted laparoscopic radical prostatectomy: feasibility study in men.

G Pasticier1, J B Rietbergen, B Guillonneau

  • 1Department of Urology, Institut Mutualiste Montsouris, University Pierre and Marie Curie, 42 Boulevard Jourdan, F-75014 Paris, France.

European Urology
|August 31, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Early detection of prostate cancer: Towards a new paradigm?]

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2023
Same author

Open IPOMs for medium/large incisional ventral hernia repairs in the French Hernia Registry: factors associated with their use and mesh-related outcomes.

Hernia : the journal of hernias and abdominal wall surgery·2023
Same author

Narrative review of PET/CT performances at biochemical recurrence in prostate cancer after radical prostatectomy and impact on patient disease management: Revue narrative à propos des performances de la TEP/TDM en cas de récidive biochimique après prostatectomie radicale dans le cancer de la prostate et impact sur la prise en charge des patients.

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2023
Same author

How PET-CT is Changing the Management of Non-metastatic Castration-resistant Prostate Cancer?: Comment la TEP-TDM Peut Modifier la Prise en Charge du Cancer de la Prostate Non Métastatique Résistant à la Castration ?

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2023
Same author

French AFU Cancer Committee Guidelines - Update 2022-2024: prostate cancer - Diagnosis and management of localised disease.

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2022
Same author

French AFU Cancer Committee Guidelines - Update 2022-2024: prostate cancer - Management of metastatic disease and castration resistance.

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2022
Same journal

Re: Ultra-hypofractionated Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma: 5-year Outcomes from a Pooled Analysis of the FASTRACK Trials.

European urology·2026
Same journal

Re: Alexander D. Sherry, Van To, Criselle D'souza, et al. Metastasis-directed Therapy With or Without Pembrolizumab for Oligometastatic Clear Cell Renal Cell Carcinoma: Pooled Analysis of Two Prospective Single-arm Phase 2 Trials. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.03.024.

European urology·2026
Same journal

Re: Hormone Therapy Use and Duration with Postoperative Radiotherapy for Recurrent Prostate Cancer: an Individual Patient Data Meta-analysis.

European urology·2026
Same journal

Re: Nguyen DD, Tadayon Najafabadi B, Lin L, et al. Effect of Prostate Cancer Screening with Prostate-specific Antigen Testing on Long-term Prostate Cancer-specific Mortality: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.04.005.

European urology·2026
Same journal

Histological Subtypes and Divergent Differentiation of Urothelial Carcinoma: Histology, Genomics, and Management Implications.

European urology·2026
Same journal

Re: Fecal Microbiota Transplantation plus Immunotherapy in Metastatic Renal Cell Carcinoma: The Phase 1 PERFORM Trial.

European urology·2026
See all related articles

This study explores robot-assisted laparoscopic radical prostatectomy, finding it safe and effective. Early results suggest benefits for surgeons, with patient outcomes comparable to traditional methods.

Area of Science:

  • Urology
  • Minimally Invasive Surgery
  • Robotic Surgery

Background:

  • Robotically assisted surgery is emerging as an alternative to traditional laparoscopic procedures.
  • Radical prostatectomy is a common treatment for prostate cancer, requiring precision and advanced techniques.

Purpose of the Study:

  • To report the initial experience with robotically assisted laparoscopic radical prostatectomy.
  • To evaluate the feasibility and early outcomes of this technique.

Main Methods:

  • Five consecutive patients underwent robotically assisted nerve-sparing radical prostatectomy using the Da Vinci system.
  • The Montsouris technique was employed by a single surgeon.
  • Patient demographics included an average age of 58, PSA 12, and Gleason score 6.

Related Experiment Videos

Main Results:

  • Mean operative time was 222 minutes, with an average blood loss of 800 cm³.
  • Postoperative outcomes included a 6.5-day catheterization, 5.5-day hospital stay, 20% urine leak rate, and 80% continence rate.
  • One patient (20%) had a positive margin.

Conclusions:

  • Robot-assisted surgery offers benefits to the surgeon, including enhanced visualization and easier urethro-anastomosis.
  • Initial patient outcomes demonstrate that the procedure is as safe and effective as conventional laparoscopic radical prostatectomy.
  • Further research is needed to clarify long-term patient benefits regarding operating time, postoperative course, and functional results.